Breaking News Instant updates and real-time market news.

CRZBY

Commerzbank

$7.62 /

-0.01 (-0.13%)

 05:03
05/23/22
 05/23
05:03
 05/23/22
05:03

Commerzbank upgraded to Buy from Hold at Societe Generale

Societe Generale analyst Saurabh Singh upgraded Commerzbank to Buy from Hold with a EUR 9 price target.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
D-Wave Quantum Inc trading halted, volatility trading pause  09:36
08/09/22
08/09
09:36
08/09/22
09:36
QBTS

D-Wave Quantum

$10.10 /

+1.1 (+12.22%)

 
ShowHide Related Items >><<
QBTS D-Wave Quantum
$10.10 /

+1.1 (+12.22%)

07/27/22 Craig-Hallum
Craig-Hallum bullish on D-Wave Quantum, initiates SPAC DPCM Capital with a Buy
07/08/22 Benchmark
DPCM Capital initiated with a Buy at Benchmark
QBTS D-Wave Quantum
$10.10 /

+1.1 (+12.22%)

02/13/22
Week in SPAC News: Quantum computing company D-Wave to merge with DPCM Capital
QBTS D-Wave Quantum
$10.10 /

+1.1 (+12.22%)

08/08/22
One new option listing and one option delisting on August 8th
Hot Stocks
News Corp trading resumes  09:35
08/09/22
08/09
09:35
08/09/22
09:35
NWS

News Corp.

$17.57 /

+0.375 (+2.18%)

 
ShowHide Related Items >><<
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

09:30 Today
News Corp trading halted, volatility trading pause
05/11/22
Realtor.com Seller's Marketplace adds four new selling options
02/28/22
News Corp. completes acquisition of OPIS for $1.15B in cash
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

07/10/22 Goldman Sachs
News Corp. downgraded to Buy from Conviction Buy at Goldman Sachs
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

08/08/22
News Corp. reports Q4 adjusted EPS 37c, consensus 7c
05/05/22
News Corp. reports Q3 adjusted EPS 16c, consensus 14c
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

06/22/22
Rupert Murdoch, Jerry Hall are getting a divorce, NY Times reports
04/20/22
News Corp. to help launch online betting brand in Australia, WSJ reports
17:00 Today
News Corp. - NWS
Recommendations
CorMedix price target lowered to $14 from $19 at JMP Securities » 09:34
08/09/22
08/09
09:34
08/09/22
09:34
CRMD

CorMedix

$7.50 /

+0.39 (+5.49%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

08/08/22
CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved
05/12/22
CorMedix believes it has sufficient resources to fund through 1H of 2023
05/12/22
CorMedix announces leadership updates, operational changes
04/07/22
CorMedix announces SAB to support commercialization, pipeline development
CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

07:40 Today Needham
CorMedix price target lowered to $12 from $20 at Needham
CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

05/12/22
CorMedix reports Q1 EPS (18c), consensus (22c)
03/29/22
CorMedix reports Q4 EPS (20c), consensus (23c)
CRMD CorMedix
$7.50 /

+0.39 (+5.49%)

08/08/22
Fly Intel: After-Hours Movers
03/29/22
Fly Intel: After-Hours Movers
08/11/22
CorMedix - CRMD
Hot Stocks
Borussia Dortmund president Reinhard Rauball will not run for re-election » 09:34
08/09/22
08/09
09:34
08/09/22
09:34
BORUF

Borussia Dortmund

$3.97 /

+ (+0.00%)

Dr. Reinhard Rauball,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BORUF Borussia Dortmund
$3.97 /

+ (+0.00%)

05/23/22
Borussia Dortmund appoints Edin Terzic as head coach
05/20/22
Borussia Dortmund, coach Marco Rose ending collaboration
BORUF Borussia Dortmund
$3.97 /

+ (+0.00%)

10/12/21 Berenberg
Borussia Dortmund price target lowered to EUR 6 from EUR 7.20 at Berenberg
BORUF Borussia Dortmund
$3.97 /

+ (+0.00%)

06/02/22
Borussia Dortmund sees 2021/2022 FY net loss EUR 25M - EUR 29M
Hot Stocks
Oportun Financial trading halted, volatility trading pause  09:33
08/09/22
08/09
09:33
08/09/22
09:33
OPRT

Oportun Financial

$10.77 /

+0.705 (+7.01%)

 
ShowHide Related Items >><<
OPRT Oportun Financial
$10.77 /

+0.705 (+7.01%)

05/24/22
Oportun Financial relases 2021 Corporate Responsibility, Sustainability Rreport
05/24/22
Oportun Financial completes $400M asset-backed securitization
OPRT Oportun Financial
$10.77 /

+0.705 (+7.01%)

08:35 Today BTIG
Oportun Financial price target lowered to $21 from $27 at BTIG
05:48 Today Barclays
Oportun Financial price target lowered to $12 from $15 at Barclays
07/11/22 Keefe Bruyette
Oportun Financial price target lowered to $14 from $21 at Keefe Bruyette
07/11/22 Barclays
Oportun Financial price target lowered to $15 from $27 at Barclays
OPRT Oportun Financial
$10.77 /

+0.705 (+7.01%)

08/08/22
Oportun Financial sees FY22 adjusted EPS $1.19-$1.34, consensus $2.49
08/08/22
Oportun Financial sees Q3 EPS (12c)-(6c), consensus 27c
08/08/22
Oportun Financial reports Q2 EPS 11c, consensus 9c
05/09/22
Oportun Financial reports Q1 EPS $1.58, consensus 59c
Hot Stocks
MEGL Stock trading halted, volatility trading pause  09:33
08/09/22
08/09
09:33
08/09/22
09:33
MEGL

Magic Empire Global

$114.01 /

-26.79 (-19.03%)

 
ShowHide Related Items >><<
MEGL Magic Empire Global
$114.01 /

-26.79 (-19.03%)

08/08/22
MEGL Stock trading resumes
08/08/22
MEGL Stock trading halted, volatility trading pause
  • 05
    Aug
MEGL Magic Empire Global
$114.01 /

-26.79 (-19.03%)

08/06/22
Opening Day: Magic Empire opening surge calls to mind AMTD Digital frenzy
Hot Stocks
BetMGM becomes official sportsbook partner of NFL in Canada » 09:32
08/09/22
08/09
09:32
08/09/22
09:32
GMVHF

Entain

$15.97 /

+0.128 (+0.81%)

, MGM

MGM Resorts

$34.50 /

-0.25 (-0.72%)

BetMGM announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMVHF Entain
$15.97 /

+0.128 (+0.81%)

06/27/22
BetMGM to become exclusive sportsbook of Audacy's BetQL Network
06/21/22
BetMGM, Sony Pictures Television, IGT to launch online Wheel of Fortune casino
06/17/22
BetMGM, Carnival partner to offer cruise ship gaming
06/14/22
Entain announces agreement to acquire BetCity
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

08/03/22
MGM Resorts repurchased over $1.1B of company stock in Q2
08/01/22
Macau reports July casino revenue down 95.3% to 398M patacas
07/28/22
Nevada reports June statewide gaming win up 8.06% to $1.28B
07/15/22
New Jersey reports June gaming revenue up 2.2% to $401.5M
GMVHF Entain
$15.97 /

+0.128 (+0.81%)

07/15/22 Barclays
Entain price target lowered to 1,950 GBp from 2,100 GBp at Barclays
07/08/22 Deutsche Bank
Entain price target lowered to 1,871 GBp from 2,034 GBp at Deutsche Bank
07/05/22 Deutsche Bank
Entain price target lowered to 2,034 GBp from 2,235 GBp at Deutsche Bank
06/24/22 Morgan Stanley
Entain price target lowered to 2,430 GBp from 2,530 GBp at Morgan Stanley
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

08/04/22 Truist
MGM Resorts price target raised to $40 from $35 at Truist
08/04/22 Deutsche Bank
MGM Resorts price target raised to $51 from $48 at Deutsche Bank
08/04/22 Wells Fargo
MGM Resorts price target raised to $58 from $49 at Wells Fargo
07/20/22 Truist
MGM Resorts price target lowered to $35 from $48 at Truist
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

08/03/22
MGM Resorts reports Q2 adjusted EPS 3c, consensus 23c
08/03/22
Notable companies reporting after market close
05/09/22
IAC reports Q1 EPS ($2.72), consensus (75c)
05/02/22
MGM Resorts reports Q1 adjusted EPS 1c, consensus (7c)
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

08/01/22
Massachusetts lawmakers reach last minute deal on sports betting, NBC reports
08/01/22
Macau reopens casinos amid record lows for July, Reuters reports
07/20/22
Macau plans to reopen casinos on July 23, Bloomberg reports
07/14/22
Genting Singapore draws takeover interest, Bloomberg reports
GMVHF Entain
$15.97 /

+0.128 (+0.81%)

07/01/22
Bet On It: Bally's enters sale-leaseback for Rhode Island casinos
06/24/22
Bet On It: Fanatics looks to enter sports betting space
04/22/22
Bet On It: Maine sports betting legislation has one stop before Governor's desk
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

08/05/22
Bet On It: Massachusetts beats buzzer to pass sports betting legislation
08/03/22
Fly Intel: After-Hours Movers
07/29/22
Bet On It: Massachusetts looks for Hail Mary bill ahead of Sunday's deadline
07/22/22
Bet On It: Massachusetts weighs sports betting as legislative session winds down
MGM MGM Resorts
$34.50 /

-0.25 (-0.72%)

06/16/22
MGM Resorts put volume heavy and directionally bearish
06/10/22
MGM Resorts put volume heavy and directionally bearish
05/02/22
MGM Resorts options imply 5.5% move in share price post-earnings
04/06/22
MGM Resorts put volume heavy and directionally bearish
Hot Stocks
News Corp trading halted, volatility trading pause  09:30
08/09/22
08/09
09:30
08/09/22
09:30
NWS

News Corp.

$17.57 /

+0.375 (+2.18%)

 
ShowHide Related Items >><<
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

05/11/22
Realtor.com Seller's Marketplace adds four new selling options
02/28/22
News Corp. completes acquisition of OPIS for $1.15B in cash
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

07/10/22 Goldman Sachs
News Corp. downgraded to Buy from Conviction Buy at Goldman Sachs
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

08/08/22
News Corp. reports Q4 adjusted EPS 37c, consensus 7c
05/05/22
News Corp. reports Q3 adjusted EPS 16c, consensus 14c
NWS News Corp.
$17.57 /

+0.375 (+2.18%)

06/22/22
Rupert Murdoch, Jerry Hall are getting a divorce, NY Times reports
04/20/22
News Corp. to help launch online betting brand in Australia, WSJ reports
17:00 Today
News Corp. - NWS
Recommendations
Ramaco Resources price target lowered to $14 from $18 at BMO Capital » 09:30
08/09/22
08/09
09:30
08/09/22
09:30
METC

Ramaco Resources

$11.20 /

+0.045 (+0.40%)

BMO Capital analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
METC Ramaco Resources
$11.20 /

+0.045 (+0.40%)

08/08/22
Ramaco Resources sees FY22 CapEx $105M-$125M
08/08/22
Ramaco Resources to acquire Maben Coal for $30M
07/14/22
Ramaco Resources announces $5M Q3 cash dividend
07/11/22
Ramaco Resources experiences methane ignition at Berwind Complex
METC Ramaco Resources
$11.20 /

+0.045 (+0.40%)

06/07/22 Jefferies
Ramaco Resources upgraded to Buy from Hold at Jefferies
03/09/22 Jefferies
Ramaco Resources price target raised to $19 from $16 at Jefferies
03/08/22 B. Riley
Ramaco Resources price target raised to $31 from $22 at B. Riley
02/03/22 B. Riley
Ramaco Resources price target raised to $22 from $20 at B. Riley
METC Ramaco Resources
$11.20 /

+0.045 (+0.40%)

08/08/22
Ramaco Resources reports Q2 EPS 74c, consensus $1.49
05/11/22
Ramaco Resources reports Q1 EPS 92c, consensus $1.62
02/24/22
Ramaco Resources reports Q4 EPS 42c, consensus 41c
09:00 Today
Ramaco Resources - METC
Recommendations
eHealth price target lowered to $8 from $12 at Truist » 09:28
08/09/22
08/09
09:28
08/09/22
09:28
EHTH

eHealth

$8.29 /

+0.52 (+6.69%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

03/01/22
eHealth sinks 22% to $12.05 after Q4 results miss estimates
03/01/22
eHealth CEO 'implementing a number of changes'
03/01/22
eHealth plans 'multi-year transformation initiative'
02/28/22
eHealth appoints Roman Rariy as COO, CTO
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

05:35 Today Citi
eHealth price target lowered to $9 from $13 at Citi
05/05/22 Deutsche Bank
eHealth price target lowered to $10 from $19 at Deutsche Bank
03/31/22 Credit Suisse
eHealth assumed with a Neutral at Credit Suisse
03/21/22 Citi
eHealth downgraded to Neutral from Buy at Citi
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

08/08/22
eHealth reports Q2 adjusted EPS ($1.15), consensus ($1.15)
08/08/22
eHealth cuts FY revenue view to $375M-$395M from $448M-$470M
05/03/22
eHealth sees FY22 revenue $448M-$470M, consensus $456.6M
05/03/22
eHealth reports Q1 adjusted EPS (91c), consensus ($1.19)
EHTH eHealth
$8.29 /

+0.52 (+6.69%)

03/21/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Syndicate
Aytu BioPharma 21.5M share Spot Secondary priced at 43c » 09:27
08/09/22
08/09
09:27
08/09/22
09:27
AYTU

Aytu BioPharma

/

+

Cantor Fitzgerald and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioPharma
/

+

09:18 Today
Aytu BioPharma announces pricing of public offering
07/20/22
Aytu BioPharma initiates AR101 Phase 3 PREVEnt trial
04/19/22
Aytu BioScience announces Fast Track designation for AR101
03/23/22
Aytu BioScience announces newly issued patent from Cotempla XR-ODT
AYTU Aytu BioPharma
/

+

07/21/22 H.C. Wainwright
Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright
05/17/22 Cantor Fitzgerald
Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald
04/28/22 H.C. Wainwright
Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright
  • 09
    Aug
08/08/22
42nd Annual Global I Growth Conference
Syndicate
Medicenna Therapeutics 13.333M share Spot Secondary priced at $1.50 » 09:25
08/09/22
08/09
09:25
08/09/22
09:25
MDNA

Medicenna Therapeutics

$1.77 /

+0.04 (+2.31%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

09:17 Today
Medicenna Therapeutics announces pricing of $20M public offering
07/27/22
Medicenna announces clinical data from Phase 1/2 ABILITY study of MDNA11
06/22/22
Medicenna Therapeutics sees cash runway late into 2Q23
06/22/22
Medicenna Therapeutics announces expected upcoming milestones
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22 Oppenheimer
Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer
03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22
Medicenna Therapeutics reports 2022 EPS (42c) vs. (35c) last year
  • 09
    Aug
Initiation
Coupang initiated with an Outperform at Macquarie » 09:24
08/09/22
08/09
09:24
08/09/22
09:24
CPNG

Coupang

$19.20 /

-0.04 (-0.21%)

Macquarie analyst Danny…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

07/15/22
Coupang rises 7.9%
07/01/22
Coupang rises 13.4%
07/01/22
Coupang rises 9.1%
05/12/22
Coupang rises 24.8%
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

06/30/22 Credit Suisse
Coupang upgraded to Outperform at Credit Suisse following underperformance
06/30/22 Credit Suisse
Coupang upgraded to Outperform from Neutral at Credit Suisse
06/29/22 Morgan Stanley
Coupang initiated with an Overweight at Morgan Stanley
05/12/22 Mizuho
Coupang price target lowered to $18 from $28 at Mizuho
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

05/11/22
Coupang reports Q1 EPS (12c), consensus (17c)
03/02/22
Coupang sees 2022 adjusted EBITDA loss less than ($400M)
03/02/22
Coupang reports Q4 EPS (23c), consensus (19c)
  • 14
    Sep
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

03/28/22
Softbank's Alibaba shares in spotlight amid stock turbulence, WSJ reports
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

07/01/22
What You Missed On Wall Street On Friday
07/01/22
What You Missed On Wall Street This Morning
07/01/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
07/01/22
Fly Intel: Pre-market Movers
08/10/22
Coupang - CPNG
CPNG Coupang
$19.20 /

-0.04 (-0.21%)

07/20/22
Unusually active option classes on open July 20th
07/01/22
Coupang call volume above normal and directionally bullish
06/17/22
Coupang call volume above normal and directionally bullish
05/31/22
Unusually active option classes on open May 31st
Recommendations
Nvidia price target lowered to $216 from $283 at Truist » 09:23
08/09/22
08/09
09:23
08/09/22
09:23
NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

Truist analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
Cathie Wood's ARK Investment bought 360K shares of Nvidia today
08/08/22
Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement
07/20/22
Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia
07/15/22
U.S. video game spending falls 11% y/y in June, says NPD
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

07:07 Today Susquehanna
Nvidia price target lowered to $210 from $220 at Susquehanna
06:41 Today Mizuho
Nvidia price target lowered to $250 from $290 at Mizuho
08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B
05/25/22
Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B
05/25/22
Nvidia reports Q1 EPS $1.36, consensus $1.29
05/25/22
Notable companies reporting after market close
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

07/28/22
House passes bill giving $52B to U.S. chipmakers, Bloomberg reports
07/28/22
Pelosi's husband sells Nvidia shares as House weighs chip bill, Reuters says
07/27/22
Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says
07/19/22
New bill to provide $52B boost to US semiconductor manufacturing, WSJ reports
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22
What You Missed On Wall Street On Monday
08/08/22
What You Missed On Wall Street This Morning
08/05/22
Here's What You Missed in Crypto This Week
07/29/22
Here's What You Missed in Crypto This Week
08/24/22
Nvidia - NVDA
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08:55 Today
Notable open interest changes for August 9th
07/21/22
NVIDIA call buyer realizes 58% same-day gains
06/21/22
Early notable gainers among liquid option names on June 21st
06/17/22
Notable open interest changes for June 17th
Hot Stocks
WISeKey implementing post-quantum algorithms » 09:22
08/09/22
08/09
09:22
08/09/22
09:22
WKEY

WISeKey

$2.66 /

+0.03 (+1.14%)

During the last two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKEY WISeKey
$2.66 /

+0.03 (+1.14%)

07/26/22
WISeKey launches WISe.ART Metaverse NFT Factory
07/25/22
WISeKey to NFT art piece by Picasso Art 'The Magic Violin'
07/08/22
WISeKey selected as collaborator by NIST for consortium project
07/06/22
WISeKey, China Museum of Finance extend cooperation for digital museum
WKEY WISeKey
$2.66 /

+0.03 (+1.14%)

05/02/22 H.C. Wainwright
WISeKey price target lowered to $4 from $11 at H.C. Wainwright
02/01/22 Maxim
WISeKey price target cut to $8 from $11 at Maxim
12/10/21 Maxim
WISeKey initiated with a Buy at Maxim
Hot Stocks
Strong Studios to develop, produce film on Joe Moglia » 09:21
08/09/22
08/09
09:21
08/09/22
09:21
BTN

Ballantyne Strong

$2.65 /

-0.02 (-0.75%)

Strong Studios, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTN Ballantyne Strong
$2.65 /

-0.02 (-0.75%)

07/14/22
Fundamental Global buys additional shares of Ballantyne Strong
06/30/22
Strong Studios, The Cartel start production on Safehaven
04/27/22
STRONG Technical Services partners with GDC Technology
04/26/22
Ballantyne Strong's STRONG/MDI to open new screen finishing facility
Recommendations
Crispr Therapeutics price target raised to $69 from $55 at Stifel » 09:21
08/09/22
08/09
09:21
08/09/22
09:21
CRSP

Crispr Therapeutics

$81.33 /

-0.02 (-0.02%)

Stifel analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

06/21/22
Crispr Therapeutics down 11% as Virtual Innovation Day continues
06/13/22
Cathie Wood's ARK Investment bought 89K shares of Crispr Therapeutics today
06/12/22
Crispr Therapeutics presents results from Phase 1 COBALT-LYM trial of CTX130
06/12/22
Vertex, Crispr Therapeutics present new data on exa-cel
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

07:20 Today Credit Suisse
Crispr Therapeutics price target raised to $90 from $74 at Credit Suisse
05:33 Today Barclays
Crispr Therapeutics downgraded to Equal Weight from Overweight at Barclays
08/08/22 Chardan
Crispr Therapeutics price target lowered to $154 from $164 at Chardan
08/02/22 Citi
Crispr Therapeutics price target raised to $83 from $53 at Citi
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

08/08/22
Crispr Therapeutics reports Q2 EPS ($2.40), consensus ($2.23)
05/09/22
Crispr Therapeutics reports Q1 EPS ($2.32), consensus ($1.94)
02/15/22
Crispr Therapeutics reports Q4 EPS ($1.84), consensus ($1.77)
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

07/25/22
Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

06/22/22
What You Missed On Wall Street On Wednesday
06/22/22
What You Missed On Wall Street This Morning
06/17/22
What You Missed On Wall Street On Friday
06/17/22
What You Missed On Wall Street This Morning
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

07/28/22
Crispr Therapeutics options imply 3.9% move in share price post-earnings
05/20/22
Largest borrow rate increases among liquid names
04/26/22
Crispr Therapeutics options imply 5.6% move in share price post-earnings
Recommendations
CarGurus price target lowered to $27 from $32 at Needham » 09:20
08/09/22
08/09
09:20
08/09/22
09:20
CARG

CarGurus

$25.77 /

+0.01 (+0.04%)

Needham analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

07/27/22
CarGurus appoints Javier Zamora as general counsel
06/06/22
CarOffer launches PremiumXchange exchange desk
05/11/22
CarGurus announces launch of CarGurus Digital Deal
03/28/22
CarGurus expands CarGurus Instant Max Cash Offer to four more states
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

08:32 Today DA Davidson
CarGurus price target lowered to $30 from $34 at DA Davidson
07:53 Today Raymond James
CarGurus price target lowered to $28 from $34 at Raymond James
07:37 Today Oppenheimer
CarGurus price target lowered to $32 from $38 at Oppenheimer
07:16 Today Truist
CarGurus price target lowered to $38 from $44 at Truist
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

08/08/22
CarGurus sees Q3 EPS 25c-28c, consensus 33c
08/08/22
CarGurus reports Q2 EPS 32c, consensus 31c
08/08/22
Notable companies reporting after market close
05/25/22
CarGurus now sees Q2 adjusted EPS 27c-30c vs. prior 26c-29c view
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

08/08/22
Fly Intel: After-Hours Movers
07/25/22
Fly Insider: CrossFirst Bankshares, Canoo among week's notable insider trades
05/10/22
Fly Intel: Pre-market Movers
02/25/22
What You Missed On Wall Street On Friday
09/07/22
CarGurus
Hot Stocks
Aytu BioPharma announces pricing of public offering » 09:18
08/09/22
08/09
09:18
08/09/22
09:18
AYTU

Aytu BioPharma

/

+

Aytu BioPharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AYTU Aytu BioPharma
/

+

07/20/22
Aytu BioPharma initiates AR101 Phase 3 PREVEnt trial
04/19/22
Aytu BioScience announces Fast Track designation for AR101
03/23/22
Aytu BioScience announces newly issued patent from Cotempla XR-ODT
03/02/22
Aytu BioScience granted orphan designation in Europe for AR101
AYTU Aytu BioPharma
/

+

07/21/22 H.C. Wainwright
Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright
05/17/22 Cantor Fitzgerald
Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald
04/28/22 H.C. Wainwright
Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright
  • 09
    Aug
08/08/22
42nd Annual Global I Growth Conference
Recommendations
Turtle Beach price target lowered to $18 from $32 at Lake Street » 09:18
08/09/22
08/09
09:18
08/09/22
09:18
HEAR

Turtle Beach

$14.00 /

-0.145 (-1.03%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

08/08/22
Turtle Beach concludes proactive outreach to potential buyers
05/16/22
Turtle Beach reaches board refreshment agreement with Donerail Group
05/15/22
Fly Intel: Top five weekend stock stories
05/10/22
Turtle Beach launches Neat Microphones brand in Europe
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

07:36 Today DA Davidson
Turtle Beach downgraded to Neutral from Buy at DA Davidson
07:30 Today Oppenheimer
Turtle Beach downgraded to Perform on weaker outlook at Oppenheimer
07:26 Today Wedbush
Turtle Beach price target lowered to $12 from $22 at Wedbush
06:38 Today Oppenheimer
Turtle Beach downgraded to Perform from Outperform at Oppenheimer
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

08/08/22
Turtle Beach sees FY22 EPS ($1.35) to (90c), consensus 89c
08/08/22
Turtle Beach reports Q2 EPS ($1.08), consensus (38c)
05/04/22
Turtle Beach backs FY22 EPS view 70c-$1.20, consensus 89c
05/04/22
Turtle Beach reports Q1 adjusted EPS (39c), consensus (52c)
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

05/15/22
Gaming gear provider Turtle Beach nears board deal with Donerail, Reuters says
03/22/22
Citron 'pounding table' on Turtle Beach, sees 'imminent' buyout
03/03/22
Citron highlights The Deal report of Turtle Beach weighing options
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

08/08/22
Fly Intel: After-Hours Movers
05/17/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
03/22/22
What You Missed On Wall Street On Tuesday
03/22/22
What You Missed On Wall Street This Morning
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

06/17/22
Turtle Beach call volume above normal and directionally bullish
05/17/22
Unusual call flow in option market yesterday
05/16/22
Calls lead puts 1200 to one in Turtle Beach with focus on 20 strike
05/16/22
Unusually active option classes on open May 16th
Hot Stocks
E2open expands partnership with Shippeo » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
ETWO

E2open

$7.41 /

+0.21 (+2.92%)

E2open and Shippeo have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETWO E2open
$7.41 /

+0.21 (+2.92%)

07/12/22
E2open falls -17.0%
07/12/22
E2open falls -11.6%
07/12/22
E2open falls -7.4%
07/11/22
E2open falls 4.6% to $7.20 after Q1 results and FY23 guidance cut
ETWO E2open
$7.41 /

+0.21 (+2.92%)

04/28/22 Loop Capital
E2open price target lowered to $12 from $16 at Loop Capital
04/21/22 BofA
E2open upgraded to Buy at BofA on accelerating revenue growth
04/21/22 BofA
E2open upgraded to Buy from Neutral at BofA
03/23/22 Colliers
E2open upgraded to Buy from Neutral at Colliers
ETWO E2open
$7.41 /

+0.21 (+2.92%)

07/11/22
E2open cuts FY23 revenue view to $672M-$680M from $681M-$689M
07/11/22
E2open reports Q1 adjusted EPS 7c, consensus 5c
07/11/22
Notable companies reporting after market close
04/27/22
E2open sees FY23 revenue $681M-$689M, consensus $640.21M
ETWO E2open
$7.41 /

+0.21 (+2.92%)

07/12/22
What You Missed On Wall Street On Tuesday
07/12/22
What You Missed On Wall Street This Morning
07/11/22
Fly Intel: After-Hours Movers
04/29/22
Proven algorithm says sell these stocks now
Hot Stocks
Medicenna Therapeutics announces pricing of $20M public offering » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
MDNA

Medicenna Therapeutics

$1.77 /

+0.04 (+2.31%)

Medicenna Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

07/27/22
Medicenna announces clinical data from Phase 1/2 ABILITY study of MDNA11
06/22/22
Medicenna Therapeutics sees cash runway late into 2Q23
06/22/22
Medicenna Therapeutics announces expected upcoming milestones
06/09/22
Medicenna announces USPTO patent that 'strengthens IP protection'
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22 Oppenheimer
Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer
03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
MDNA Medicenna Therapeutics
$1.77 /

+0.04 (+2.31%)

06/22/22
Medicenna Therapeutics reports 2022 EPS (42c) vs. (35c) last year
  • 09
    Aug
Hot Stocks
Ralph Lauren seeing broad based strength across all regions » 09:17
08/09/22
08/09
09:17
08/09/22
09:17
RL

Ralph Lauren

$101.19 /

+0.96 (+0.96%)

Says not immune to macro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

06/24/22
Ralph Lauren announces nomination of Cupp to board of directors
06/24/22
Ralph Lauren publishes 2022 Global Citizenship & Sustainability Report
05/24/22
Ralph Lauren expects all 3 regions to drive positive revenue growth this year
05/24/22
Ralph Lauren sees growth in owned and wholesale digital in FY23
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

08/05/22 Credit Suisse
Ralph Lauren price target lowered to $120 from $130 at Credit Suisse
08/01/22 Deutsche Bank
Ralph Lauren price target lowered to $99 from $101 at Deutsche Bank
07/21/22 Goldman Sachs
Ralph Lauren price target lowered to $78 from $85 at Goldman Sachs
07/15/22 UBS
Ralph Lauren price target lowered to $129 from $162 at UBS
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

08:06 Today
Ralph Lauren backs FY23 revenue view up high single digits, consensus $6.38B
08:05 Today
Ralph Lauren sees Q2 revenue up 11%, consensus $1.58B
08:04 Today
Ralph Lauren reports Q1 adjusted EPS $1.88 vs. $2.29 last year
08/08/22
Notable companies reporting before tomorrow's open
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

02/22/22
LVMH held talks in recent years on Ralph Lauren deal potential, Axios says
RL Ralph Lauren
$101.19 /

+0.96 (+0.96%)

05/24/22
What You Missed On Wall Street On Tuesday
05/24/22
What You Missed On Wall Street This Morning
05/23/22
What You Missed On Wall Street On Monday
05/23/22
What You Missed On Wall Street This Morning
09:00 Today
Ralph Lauren - RL
Recommendations
SI-Bone price target lowered to $24 from $28 at Needham » 09:16
08/09/22
08/09
09:16
08/09/22
09:16
SIBN

SI-Bone

$16.52 /

-0.21 (-1.26%)

Needham analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

06/13/22
SI-Bone announces FDA clearance for expanded indication of iFuse-TORQ system
05/31/22
SI-Bone receives FDA 510(k) clearance for iFuse Bedrock Granite
04/19/22
SI-Bone announces NTAP for adult spinal deformity treatment
SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

05/10/22 Canaccord
SI-Bone price target lowered to $25 from $32 at Canaccord
04/07/22 Cantor Fitzgerald
SI-Bone assumed with an Overweight at Cantor Fitzgerald
12/21/21 Truist
SI-Bone price target lowered to $30 from $35 at Truist
11/09/21 Needham
SI-Bone price target lowered to $32 from $37 at Needham
SIBN SI-Bone
$16.52 /

-0.21 (-1.26%)

08/08/22
SI-Bone backs FY22 revenue view $106M-$108M, consensus $107.26M
08/08/22
SI-Bone reports Q2 EPS (54c) vs. (42c) last year
05/09/22
SI-Bone backs prior FY22 revenue view $106M-$108M, consensus $107.35M
05/09/22
SI-Bone reports Q1 EPS (52), consensus (43c)
08/08/22
42nd Annual Global I Growth Conference
Hot Stocks
Nova Vision Acquisition announces additional contribution to trust account » 09:16
08/09/22
08/09
09:16
08/09/22
09:16
NOVV

Nova Vision Acquisition

$10.06 /

+ (+0.00%)

Nova Vision Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.